Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

AI spots more pancreatic cancer than radiologists
The use of artificial intelligence has the potential to significantly improve the diagnosis of pancreatic cancer, new data suggest.
Telix says new kidney cancer imaging agent alters treatment plans for 50% of patients
The positive findings come after the U.S. Food and Drug Administration previously shared concerns related to sterility assurance issues during the drug’s production.
ASTRO releases new radiation therapy guidelines for gastric cancers
Many forms of the disease are identified at later stages, making treatment and management complex and multifaceted.
Some PET exams may be overutilized in oncology
In 2020 alone, there were more than 2 million 18F-FDG PET/CT scans conducted in the United States.
AI bests radiologists at predicting lung cancer treatment responses
More accurate response assessments could give providers an opportunity to proactively manage treatment decisions in the future.

AI spots more pancreatic cancer than radiologists

The use of artificial intelligence has the potential to significantly improve the diagnosis of pancreatic cancer, new data suggest.

Telix says new kidney cancer imaging agent alters treatment plans for 50% of patients

The positive findings come after the U.S. Food and Drug Administration previously shared concerns related to sterility assurance issues during the drug’s production.

Routine IR procedure could treat endometriosis.

ASTRO releases new radiation therapy guidelines for gastric cancers

Many forms of the disease are identified at later stages, making treatment and management complex and multifaceted.

Some PET exams may be overutilized in oncology

In 2020 alone, there were more than 2 million 18F-FDG PET/CT scans conducted in the United States.

AI bests radiologists at predicting lung cancer treatment responses

More accurate response assessments could give providers an opportunity to proactively manage treatment decisions in the future.

1st patient dosed with new radiopharmaceutical targeting cancer bone pain

The treatment can offer patients a more potent, cost-effective alternative providing long-lasting relief compared to current pain regimens.

Novartis seeks to expand use of prostate therapy Pluvicto, citing positive trial results

An expanded approval could potentially double the number of patients eligible for treatment with the therapy, first approved in 2022.

Daniel Addison, MD, Director of Translational Research in the Cardiology Division and Associate Director for Survivorship and Outcomes Research in the Harold C. Simmons Comprehensive Cancer Center. He also holds the Audre and Bernard Rapport Endowed Chair in Cardiovascular Research, UT Southwestern Medical Center. explains the health disparities and inequities involved in cardio-oncology.

How clinicians can combat health disparities in cardio-oncology

Researchers, for example, could improve disparities by performing their tests on more diverse groups of patients. Daniel Addison, MD, shared his perspective with Cardiovascular Business.